Suchergebnisse - "Remission Induction"

PubPharm (354)

81

A study of volasertib in combination with low-dose cytarabine in patients aged 65 years and above with previously untreated acute myeloid leukaemia, who are ineligible for intensive remission induction therapy : A phase III randomised, double-blind, controlled, parallel group study of intravenous volasertib in combination with subcutaneous low-dose cytarabine vs. placebo + low-dose cytarabine in patients = 65 years with previously untreated acute myeloid leukaemia, who are ineligible for intensive remission induction therapy. - POLO-AML-2

enthalten in: WHO International Clinical Trials Registry Platform | 2021

82

A study of volasertib in combination with low-dose cytarabine in patients aged 65 years and above with previously untreated acute myeloid leukaemia, who are ineligible for intensive remission induction therapy : A phase III randomised, double-blind, controlled, parallel group study of intravenous volasertib in combination with subcutaneous low-dose cytarabine vs. placebo + low-dose cytarabine in patients = 65 years with previously untreated acute myeloid leukaemia, who are ineligible for intensive remission induction therapy. - POLO-AML-2

enthalten in: WHO International Clinical Trials Registry Platform | 2021

83

A study of volasertib in combination with low-dose cytarabine in patients aged 65 years and above with previously untreated acute myeloid leukaemia, who are ineligible for intensive remission induction therapy : A phase III randomised, double-blind, controlled, parallel group study of intravenous volasertib in combination with subcutaneous low-dose cytarabine vs. placebo + low-dose cytarabine in patients = 65 years with previously untreated acute myeloid leukaemia, who are ineligible for intensive remission induction therapy. - POLO-AML-2

enthalten in: WHO International Clinical Trials Registry Platform | 2021

84

Clinical and Sociodemographic Associates of Remission from Positive Symptoms in Schizophrenia

enthalten in: East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan | 2021

von Jana, A.

85

Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy

enthalten in: Kidney360 | 2021

von Pathak, V. | Venkatesan, M. | Regunathan-Shenk, R.

86

Postneoadjuvante Therapiekonzepte beim Mammakarzinom

enthalten in: Best Practice Onkologie | 2021

von Ettl, J. | Stewart-da Coll, J.

87

Postneoadjuvante Therapiekonzepte beim Mammakarzinom

enthalten in: Best practice Onkologie | 2021

von Ettl, J. | Stewart-da Coll, J.

88

Postneoadjuvante Therapiekonzepte beim Mammakarzinom

enthalten in: Best Practice Onkologie | 2021

von Ettl, J. | Stewart-da Coll, J.

89

The Optimal Dose of Tacrolimus in Combination Therapy with an Anti-TNFα Antibody in a Mouse Colitis Model

enthalten in: Biological & pharmaceutical bulletin | 2021

von Murakami, Y. | Fujiya, M. | Konishi, H. | +12

90

Cachexia, Following Flowers

enthalten in: HCA healthcare journal of medicine | 2021

von O'Bryant, S.